Clinical Report: Depression and Anxiety Symptoms in Adults With Type 1 Diabetes
Overview
In a survey analysis of 58,106 US adults, moderate or severe depressive symptoms were reported by 17% of adults with type 1 diabetes (T1D), and moderate or severe anxiety symptoms by 16%. Both estimates were higher than those among adults with type 2 diabetes or no diabetes; the study authors noted limitations including self-reported diabetes classification and a small T1D subgroup.
Background
Diabetes management is a lifelong responsibility that can affect mental health and diabetes outcomes, including glycemic stability and complications. The supplied study context notes associations between depression and anxiety in people with diabetes and poorer glycemic control and increased complication risk. The 2026 American Diabetes Association Standards of Care call for routine psychosocial screening and follow-up, including screening for depression and anxiety with validated instruments. The study assessed recent symptoms, not diagnoses established through clinical interviews.
Data Highlights
| Measure | Type 1 diabetes | Type 2 diabetes | No diabetes |
|---|---|---|---|
| Participants in survey analysis | 326 | 5,802 | 51,978 |
| Moderate or severe depressive symptoms | 17% | 12% | 7% |
| Moderate or severe anxiety symptoms | 16% | 9% | 6% |
| Severe depressive symptoms | 10% | 5% | 3% |
| Severe anxiety symptoms | 8% | 4% | 3% |
| Moderate or severe depression, female vs male participants | 22% vs 11% | — | |
| Moderate or severe anxiety, female vs male participants | 19% vs 13% | — | |
Data were from the 2019 and 2022 National Health Interview Survey. Diabetes classification was based on self-reported diagnosis and current insulin use. Moderate symptoms were defined as scores of 10–14 and severe symptoms as scores of 15 or higher on the PHQ-8 or GAD-7.
Key Findings
- Among adults with T1D, 17% reported moderate or severe depressive symptoms, compared with 12% of adults with type 2 diabetes and 7% of adults without diabetes; the reported differences were statistically significant.
- Moderate or severe generalized anxiety symptoms were reported by 16% of adults with T1D, 9% with type 2 diabetes, and 6% without diabetes; the reported differences were statistically significant.
- Severe depressive symptoms affected 10% of adults with T1D, versus 5% with type 2 diabetes and 3% without diabetes. Severe anxiety symptoms affected 8%, 4%, and 3%, respectively.
- Within the T1D group, moderate or severe anxiety symptoms were most prevalent among adults aged 18–44 years (22%); depressive symptoms were most prevalent among those aged 45–64 years (20%).
- Among adults with T1D and less than a high school education, 24% reported moderate or severe depressive symptoms and 32% reported moderate or severe anxiety symptoms. Corresponding estimates for those with a college education or higher were 16% and 13%.
- The study authors cautioned that self-reported diabetes subtype could result in misclassification, the T1D sample limited precision of subgroup estimates, and symptom measures covering the prior 2 weeks were not confirmed by clinical interviews. The survey also did not assess diabetes-specific psychosocial burdens.
Clinical Implications
The 2026 ADA Standards of Care call for routine psychosocial screening and follow-up, including validated screening for depression and anxiety and referral to qualified behavioral health professionals when needed. The study authors stated that better mental health screening, especially in high-risk populations, is essential for improving diabetes management and quality of life.
Conclusion
In this US survey analysis, adults with T1D reported moderate or severe depressive and anxiety symptoms more often than adults with type 2 diabetes or no diabetes. The estimates describe self-reported symptoms and should be interpreted in light of the study's stated measurement and sampling limitations.
Related Resources & Content
- American Diabetes Association, Diabetes Care, 2026 — Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2026
- The Journal of Clinical Endocrinology & Metabolism, 2025 — The Interplay Between Mental Health and Diabetes Care Management
- Annals of Internal Medicine, year not provided — National Health Interview Survey analysis of depressive and anxiety symptoms in adults with type 1 diabetes
- Frontiers in Pediatrics — Low Caregiver State Anxiety is Associated with Worse Glycemic Control in Youth with Type 1 Diabetes Mellitus: A Cross-Sectional Study
- BMC Psychiatry (Springer) — Associations between COVID pandemic-related post-traumatic stress disorder symptoms and self-care behaviors, fear of hypoglycemia, and depressive symptoms among Chinese adults with type 2 diabetes in the post-pandemic era
- Frontiers in Endocrinology — Lipids and glucose fluctuations are associated with clinically diagnosed depression in older adults with type 2 diabetes
- Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2026
- The Interplay Between Mental Health and Diabetes Care Management
- 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2026 | Diabetes Care | American Diabetes Association
- Global prevalence and correlates of diabetes distress in type 1 diabetes: A systematic review and meta-analysis.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
